These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11886411)

  • 1. Use of mitomycin C in the treatment of corneal conjunctival intraepithelial neoplasia.
    Daniell M; Maini R; Tole D
    Clin Exp Ophthalmol; 2002 Apr; 30(2):94-8. PubMed ID: 11886411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
    Shields CL; Naseripour M; Shields JA
    Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Wilson MW; Hungerford JL; George SM; Madreperla SA
    Am J Ophthalmol; 1997 Sep; 124(3):303-11. PubMed ID: 9439356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term results of topical mitomycin C 0.02% for primary and recurrent conjunctival-corneal intraepithelial neoplasia.
    Ballalai PL; Erwenne CM; Martins MC; Lowen MS; Barros JN
    Ophthalmic Plast Reconstr Surg; 2009; 25(4):296-9. PubMed ID: 19617789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience.
    Frucht-Pery J; Sugar J; Baum J; Sutphin JE; Pe'er J; Savir H; Holland EJ; Meisler DM; Foster JA; Folberg R; Rozenman Y
    Ophthalmology; 1997 Dec; 104(12):2085-93. PubMed ID: 9400769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia.
    Gebhardt DO
    Am J Ophthalmol; 1998 Mar; 125(3):416-7. PubMed ID: 9512172
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C.
    Haas K; Ben-Dor D; Levartovsky S
    Arch Ophthalmol; 1999 Apr; 117(4):544-5. PubMed ID: 10206591
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitomycin C therapy for conjunctival-corneal intraepithelial neoplasia.
    Papandroudis AA; Dimitrakos SA; Stangos NT
    Cornea; 2002 Oct; 21(7):715-7. PubMed ID: 12352093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical 0.002% mitomycin C for the treatment of conjunctival-corneal intraepithelial neoplasia and squamous cell carcinoma.
    Prabhasawat P; Tarinvorakup P; Tesavibul N; Uiprasertkul M; Kosrirukvongs P; Booranapong W; Srivannaboon S
    Cornea; 2005 May; 24(4):443-8. PubMed ID: 15829803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of recurrent corneal intraepithelial neoplasia with topical mitomycin C.
    Tseng SH; Tsai YY; Chen FK
    Cornea; 1997 Sep; 16(5):595-7. PubMed ID: 9294697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of mitomycin C for corneal-conjunctival intraepithelial neoplasia: management options--case reports].
    de Figueirêdo RS; de Figueirêdo ES
    Arq Bras Oftalmol; 2006; 69(3):407-11. PubMed ID: 16936968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C 0.02%].
    Ramos-López JF; Martínez-Costa Pérez R; Cisneros Lanuza AL; Francés Muñoz E; Monte Boque E; Muñoz Gómez MC; López-Sánchez EV; Menezo Rozalén JL
    Arch Soc Esp Oftalmol; 2004 Aug; 79(8):375-8. PubMed ID: 15306963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C.
    Heigle TJ; Stulting RD; Palay DA
    Am J Ophthalmol; 1997 Sep; 124(3):397-9. PubMed ID: 9439368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia.
    Dudney BW; Malecha MA
    Am J Ophthalmol; 2004 May; 137(5):950-1. PubMed ID: 15126170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Topical treatment with mitomycin C in considerably raised conjunctival intraepithelial neoplasia].
    Rodríguez-Pérez C; Del Campo Z; Wolley-Dod C; Gris O
    Arch Soc Esp Oftalmol; 2002 Dec; 77(12):685-8. PubMed ID: 12471516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ocular surface squamous neoplasia with Mitomycin C.
    Gupta A; Muecke J
    Br J Ophthalmol; 2010 May; 94(5):555-8. PubMed ID: 20447963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
    Lee JH; Kim YH; Kim MS; Kim EC
    Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea.
    Yeatts RP; Engelbrecht NE; Curry CD; Ford JG; Walter KA
    Ophthalmology; 2000 Dec; 107(12):2190-5. PubMed ID: 11097594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
    Bahrami B; Greenwell T; Muecke JS
    Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.